![FDA approves Merck’s drug for rare, deadly lung condition](https://newsology.co.in/wp-content/uploads/https://image.cnbcfm.com/api/v1/image/107369253-1707165954401-gettyimages-1988346281-scooter262380_s7vzl5mj.jpeg?v=1707166018&w=1920&h=1080)
FDA approves Merck’s drug for rare, deadly lung condition
[ad_1] The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with pulmonary arterial hypertension. The…